Frontlight ResearchEarly access
Multiple sclerosis trials in France
52 of 71 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
- Where
- Ajaccio, Bayonne, Besancon Cedex, Bordeaux, Caen Cedex 9, Clermont Ferrand Cedex 1, Creteil, Dijon, La Tronche, Libourne Cedex, Lille Cedex, Marseille, Montpellier Cedex 5, Nancy, Nantes Cedex 1, Nice, Nîmes, Pau Cedex, Poissy, Rennes, Rouen Cedex, Strasbourg Cedex 2, Suresnes, Toulouse, Tours
- Age
- 40 years and over
- People
- 250
- Run by
- University Hospital, Montpellier
See details and how to joinNCT07189325 · EU 2024-513292-40-00 - No phaseTaking peopleDiagnostic Value of eVOG
- Where
- Nice
- Age
- 18 years and over
- People
- 150
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05776511 - No phaseNot yet taking people in FrancePRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple Sclerosis
- Where
- Angers, Antibes, Bordeaux, Brest, Caen, Clermont-Ferrand, Colmar, Créteil, Dijon, Épinal, Grenoble, La Roche-sur-Yon, Lille, Lyon, Marseille, Metz, Montpellier, Nancy, Nice, Nîmes, Paris, Poissy, Poitiers, Rennes, Rouen, Saint-Brieuc, St-Malo, Strasbourg, Toulouse, Tours, Vannes
- Age
- 18 years to 50 years
- People
- 448
- Run by
- Nantes University Hospital
See details and how to joinNCT07647952 - No phaseTaking peopleDeployment o the Multidisciplinary Prospective Cohort Imminent
- Where
- Lille
- Age
- 18 years and over
- People
- 2,200
- Run by
- University Hospital, Lille
See details and how to joinNCT04334031 - No phaseTaking peopleMRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
- Where
- Poitiers
- Age
- 18 years and over
- People
- 50
- Run by
- Poitiers University Hospital
See details and how to joinNCT05491031 - No phaseNot yet taking people in FranceMulticenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?
- Where
- Colmar, Dijon, Haguenau, Metz, Mulhouse, Nancy, Reims, Strasbourg
- Age
- 18 years to 70 years
- People
- 136
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07545889 - Phase 3Taking peopleFor patients with active multiple sclerosis, impact of annual versus semi-annual infusions of ocrelizumab after 2 years of initial treatment on the absence of radiological disease activity at 2 years: a multicentre randomised controlled non-inferiority trial
- Where
- Bron, Creteil Cedex, Gonesse, Grenoble Cedex 09, Limoges Cedex 1, Nice, Paris, Paris Cedex 13, Poissy, Strasbourg Cedex 2, Suresnes
- Age
- 18 years and over
- People
- 244
- Run by
- Hopital Fondation Adolphe De Rothschild
See details and how to join2023-505420-62-00 - No phaseTaking peopleEXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis
- Where
- Berck, Créteil, Dijon, Gaillac-Toulza, Garches, Lomme, Lyon, Nice, Rennes, Saint-Genis-Laval, Strasbourg
- Age
- 18 years and over
- People
- 77
- Run by
- Otto Bock France SNC
See details and how to joinNCT07252895 - No phaseTaking peopleFrom Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
- Where
- Nantes
- Age
- 18 years and over
- People
- 130
- Run by
- Nantes University Hospital
See details and how to joinNCT04873492 - No phaseTaking peopleExploring Cortical Remyelination in Children With Multiple Sclerosis
- Where
- Le Kremlin-Bicêtre, Paris
- Age
- 12 years to 18 years
- People
- 40
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05258396 - Phase 2/3Taking peopleStudy of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)
- Where
- Bron, Orsay Cedex, Paris Cedex 13, Rennes, Rennes Cedex, Toulouse, Vandoeuvre Les Nancy
- Age
- 18 years to 64 years
- People
- 41
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06280742 · EU 2023-510304-53-00 - No phaseTaking peopleClinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
- Where
- Paris
- Age
- 18 years to 99 years
- People
- 113
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05772637 - Phase 3Active, not recruitingRItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
- Where
- Brest Cedex 2, Bron Cedex, Caen Cedex 9, Clermont-Ferrand, Creteil Cedex, Gonesse, Grenoble Cedex 9, Limoges, Lomme Cedex, Marseille, Montpellier Cedex 5, Nancy, Nice, Nimes Cedex 9, Paris, Poissy, Poitiers, Pontoise, Quimper Cedex, Rennes, Rouen Cedex, Saint-Herblain, Saint-Malo Cedex, Strasbourg Cedex, Suresnes, Toulouse
- Age
- 18 years to 55 years
- People
- 386
- Run by
- Rennes University Hospital
See details and how to joinNCT05758831 · EU 2022-501027-25-01 - No phaseTaking peopleComparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
- Where
- Nice
- Age
- 18 years to 60 years
- People
- 150
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07135752 - Phase 1Taking peopleAllogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
- Where
- Créteil, Rennes
- Age
- 18 years to 55 years
- People
- 10
- Run by
- Rennes University Hospital
See details and how to joinNCT06592703 - No phaseTaking peopleTranscutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
- Where
- Lille
- Age
- 18 years to 65 years
- People
- 68
- Run by
- University Hospital, Lille
See details and how to joinNCT04573673 - No phaseNot yet taking people in FranceEvaluation of the Clinical Contribution of Quantitative MRI in Neuro-imaging
- Where
- Montpellier
- Age
- 18 years to 52 years
- People
- 272
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT07245589 - No phaseTaking peopleThe Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
- Where
- Clermont-Ferrand
- Age
- 18 years to 50 years
- People
- 396
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT06426316 - No phaseTaking peopleMontpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic
- Where
- Montpellier
- Age
- 18 years to 59 years
- People
- 400
- Run by
- University Hospital, Montpellier
See details and how to joinNCT05962177 - No phaseTaking peopleRemediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients
- Where
- Arras, Lens, Lille, Lomme, Rouen
- Age
- 18 years to 65 years
- People
- 150
- Run by
- Lille Catholic University
See details and how to joinNCT04694534 - No phaseTaking peoplePredictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
- Where
- Lille
- Age
- 18 years to 55 years
- People
- 200
- Run by
- University Hospital, Lille
See details and how to joinNCT06455332 - Phase 2Active, not recruitingTOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
- Where
- Besancon Cedex, Nancy, Paris Cedex 13, Rennes Cedex 9, Strasbourg Cedex 2
- Age
- 18 years to 55 years
- People
- 40
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT03910738 · EU 2024-517845-14-00 - No phaseTaking people3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)
- Where
- Bordeaux
- Age
- 18 years and over
- People
- 60
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT05227092 - No phaseTaking peopleInterest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity (MUSIBOT)
- Where
- Clermont-Ferrand
- Age
- 18 years and over
- People
- 80
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT06920524 - Phase 1Taking peopleTrial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis
- Where
- Saint-Herblain
- Age
- 18 years to 45 years
- People
- 7
- Run by
- Nantes University Hospital
See details and how to joinNCT02912897 · EU 2024-515563-55-00